Literature DB >> 17695449

Expression of MMP-10 in lung cancer.

Xiaoying Zhang1, Shaowei Zhu, Guanghua Luo, Lu Zheng, Jiang Wei, Jiang Zhu, Qingfeng Mu, Ning Xu.   

Abstract

BACKGROUND: Matrix metalloproteinase (MMP)-mediated degradation of the extracellular matrix is a key point in tumor development and expansion. MMP-10 is one of the most important and well-characterized members of the MMP family. In the present study, we examined MMP-10 mRNA and protein levels in non-small cell lung cancer (NSCLC). PATIENTS AND METHODS: Three endogenous reference genes including GAPDH, beta-actin and 18S rRNA, and MMP-10 mRNA levels were determined using real-time RT-PCR. Immunohistochemical staining was applied to examine MMP-10 protein levels. Both tumor and adjacent normal lung tissues were collected from 32 NSCLC patients. The mRNA levels of GAPDH, beta-actin and 18S rRNA exhibited great differences in tumor tissues and in the adjacent normal tissues. The ratio of mRNA levels in the tumor tissues compared to the adjacent normal tissues followed the pattern GAPDH > beta-actin > 18S rRNA. Thereafter, we chose 18S rRNA as the reference gene for MMP-10 mRNA level determinations. MMP-10 mRNA levels in tumor tissues were significantly lower than those in the adjacent normal tissues (p =0.0423). However, the MMP-10 protein levels were higher in the tumor tissues than in the adjacent normal tissues (p=0.0055). The MMP-10 mRNA level was positively-correlated to the MMP-10 protein level in tumor tissues (r=0.4672, p=0.0161), but this correlation was not seen in the adjacent normal tissues (r=-0.0030, p=0.9891).
CONCLUSION: There were no statistical differences in MMP-10 mRNA levels and protein levels in relation to patient's gender, age, tumor stages, tumor size, lymph node metastasis or tumor histological type.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17695449

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Differential expression of degradome components in cutaneous squamous cell carcinomas.

Authors:  Nijaguna B Prasad; Anne C Fischer; Alice Y Chuang; Jerry M Wright; Ting Yang; Hua-Ling Tsai; William H Westra; Nanette J Liegeois; Allan D Hess; Anthony P Tufaro
Journal:  Mod Pathol       Date:  2013-12-20       Impact factor: 7.842

2.  Overexpression of MMP-9 and HIF-1α in Breast Cancer Cells under Hypoxic Conditions.

Authors:  Jae Young Choi; Yeon Soo Jang; Sun Young Min; Jeong Yoon Song
Journal:  J Breast Cancer       Date:  2011-06-18       Impact factor: 3.588

3.  Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis.

Authors:  Sonia Blanco-Prieto; Leticia Barcia-Castro; María Páez de la Cadena; Francisco Javier Rodríguez-Berrocal; Lorena Vázquez-Iglesias; María Isabel Botana-Rial; Alberto Fernández-Villar; Loretta De Chiara
Journal:  BMC Cancer       Date:  2017-12-05       Impact factor: 4.430

4.  Oncogenic Mutation BRAF V600E Changes Phenotypic Behavior of THLE-2 Liver Cells through Alteration of Gene Expression.

Authors:  Magdalena Śmiech; Paweł Leszczyński; Christopher Wardell; Piotr Poznański; Mariusz Pierzchała; Hiroaki Taniguchi
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

5.  Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis.

Authors:  Akihiko Sokai; Tomohiro Handa; Kiminobu Tanizawa; Toru Oga; Kazuko Uno; Tatsuaki Tsuruyama; Takeshi Kubo; Kohei Ikezoe; Yoshinari Nakatsuka; Kazuya Tanimura; Shigeo Muro; Toyohiro Hirai; Sonoko Nagai; Kazuo Chin; Michiaki Mishima
Journal:  Respir Res       Date:  2015-09-29

6.  Matrix metalloproteinase-10 promotes tumor progression through regulation of angiogenic and apoptotic pathways in cervical tumors.

Authors:  Ge Zhang; Makito Miyake; Adrienne Lawton; Steve Goodison; Charles J Rosser
Journal:  BMC Cancer       Date:  2014-05-03       Impact factor: 4.430

7.  Matrix metalloproteinase-10 regulates stemness of ovarian cancer stem-like cells by activation of canonical Wnt signaling and can be a target of chemotherapy-resistant ovarian cancer.

Authors:  Tasuku Mariya; Yoshihiko Hirohashi; Toshihiko Torigoe; Yuta Tabuchi; Takuya Asano; Hiroshi Saijo; Takafumi Kuroda; Kazuyo Yasuda; Masahito Mizuuchi; Tsuyoshi Saito; Noriyuki Sato
Journal:  Oncotarget       Date:  2016-05-03

8.  Apolipoprotein M inhibits proliferation and migration of larynx carcinoma cells.

Authors:  Haixiang Xue; Miaomei Yu; Ying Zhou; Jun Zhang; Qinfeng Mu; Tongbing Chen; Guanghua Luo; Jisheng Liu
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.